mTORC2

Rapamycin complex 2 (mTORC2) functions as a serine/threonine kinase complex that integrates extracellular and intracellular signals to regulate cell survival, metabolism, and cytoskeletal organization^[1][2]. Mechanistically, mTORC2 mediates phosphorylation of AGC family kinases including Akt, PKC, and SGK1, influencing cell growth, differentiation, and ion transport^[1][3]. Activation of mTORC2 occurs downstream of growth factor receptors and G-protein coupled receptors, and is modulated by stress conditions such as nutrient limitation^[1][4]. In disease models, mTORC2 dysregulation contributes to cancer progression, epithelial-mesenchymal transition, and resistance to apoptosis, as observed in colorectal cancer and pheochromocytoma models^[5][6][7]. Compared with mTORC1, mTORC2 uniquely phosphorylates Akt at Ser473 and SGK1 at Ser422, while being less sensitive to rapamycin inhibition, indicating functional and regulatory specificity^[3][8][9]. Structural studies reveal that mTORC2 assembly depends on core subunits such as Rictor and SIN1, which determine its localization and substrate specificity^[10][11]. For experimental applications, dual mTORC1/2 inhibitors or genetic knockouts targeting Rictor and SIN1 effectively modulate mTORC2-dependent signaling, autophagy, and cell survival in preclinical studies^[6][12][13]. These insights position mTORC2 as a critical regulatory node for targeted therapeutic interventions and mechanistic studies of cellular growth and stress responses^[1][2][13].